Bilirubin Induces A1-Like Reactivity of Astrocyte

Astrocytes play an important role in the pathogenesis of bilirubin neurotoxicity, and activated astrocytes might be potential mediators of neuroinflammation processes contributing to neuronal cell death and tissue injury. Recent studies have reported that activated microglia induce two types of reactive astrocytes. A1 astrocytes could cause neuronal death and synaptic damage, as well as impaired phagocytosis. Therefore, the purpose of this study was to investigate whether unconjugated bilirubin (UCB)-induced A1-like astrocytes take on a neuroinflammation type and the underlying regulatory mechanisms. In this study, primary cortical astrocytes were treated with UCB in vitro. We detected the expression of complement component 3 (C3), S100 calcium binding protein A10 (S100A10), nuclear factor kappa B (NF-kappa B), NLR family pyrin domain containing 3 (NLRP3), activated caspase-1, gasdermin D N-terminal (GSDMD-N), PSD95, synaptophysin (SYP), the transcription levels of interleukin (IL)-1 beta and IL-18, and the survival rate of astrocytes after UCB treatment. The results showed that an increase in C3 was accompanied by a decrease in S100A10, and that A1-like astrocytes were functionally expressed after UCB stimulation. Meanwhile, the NF-kappa B and caspase-1 pathways were activated after UCB stimulation. After adding the NF-kappa B-specific inhibitor trans-activator of transcriptional-NEMO-binding domain (TAT-NBD) and caspase-1 specific inhibitor VX-765, the survival rate of astrocytes and neurons increased, whereas the protein expression of C3, NF-kappa B, NLRP3, activated caspase-1, and GSDMD-N decreased, and the mRNA levels of IL-1 beta and IL-18 reduced. Thus, we concluded that UCB stimulates the activation of A1-like astrocytes. Inhibition of NF-kappa B and caspase-1 alleviated A1-like astrocytes and exerted anti-inflammatory protective effects.

Automated summary

This study investigated the neuroinflammation type of A1-like astrocytes induced by unconjugated bilirubin (UCB) and its underlying regulatory mechanisms. The results showed that UCB stimulation activated A1-like astrocytes, and the inhibition of NF-Kappa B and caspase-1 alleviated A1-like astrocytes and exerted anti-inflammatory protective effects.